Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells

Michiko Horiguchi, Satoru Koyanagi, Ahmed M. Hamdan, Keisuke Kakimoto, Naoya Matsunaga, Chikamasa Yamashita, Shigehiro Ohdo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The sensitivity of cancer cells to chemotherapeutic agents varies according to circadian time. Most chemotherapeutic agents ultimately cause cell death through cell-intrinsic pathways as an indirect consequence of DNA damage. The p53 tumor suppressor gene (TRP53) configures the cell deaths induced by chemotherapeutic agents. In this study, we show that the transcription factor ATF4, a component of the mammalian circadian clock, functions in circadian accumulation of p53 protein in tumor cells. In murine fibroblast tumor cells, ATF4 induced the circadian expression of p19ARF (Cdkn2a). Oscillation of p19ARF interacted in a time-dependent manner with MDM2, a specific ubiquitin ligase of p53, resulting in a rhythmic prevention of its degradation by MDM2. Consequently, the half-life of p53 protein varied in a circadian timedependent manner without variation in mRNA levels. The p53 protein accumulated during those times when the p19ARF-MDM2 interaction was facilitated. Notably, the ability of the p53 degradation inhibitor nutlin-3 to kill murine fibroblast tumor cells was enhanced when the drug was administered at those times of day during which p53 had accumulated. Taken together, these results suggested that ATF4-mediated regulation of the p19ARF-MDM2 pathway underlies the circadian accumulation of p53 protein in malignant cells. Furthermore, they suggest an explanation for how the sensitivity of cancer cells to chemotherapeutic agents is enhanced at those times of day when p53 protein has accumulated, as a result of circadian processes controlled by ATF4.

Original languageEnglish
Pages (from-to)2639-2649
Number of pages11
JournalCancer Research
Volume73
Issue number8
DOIs
Publication statusPublished - Apr 15 2013

Fingerprint

Neoplasms
Proteins
Activating Transcription Factor 4
Cell Death
Fibroblasts
Circadian Clocks
Ligases
Ubiquitin
Tumor Suppressor Genes
DNA Damage
Half-Life
Cause of Death
Messenger RNA
Pharmaceutical Preparations
nutlin 3

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells. / Horiguchi, Michiko; Koyanagi, Satoru; Hamdan, Ahmed M.; Kakimoto, Keisuke; Matsunaga, Naoya; Yamashita, Chikamasa; Ohdo, Shigehiro.

In: Cancer Research, Vol. 73, No. 8, 15.04.2013, p. 2639-2649.

Research output: Contribution to journalArticle

Horiguchi, Michiko ; Koyanagi, Satoru ; Hamdan, Ahmed M. ; Kakimoto, Keisuke ; Matsunaga, Naoya ; Yamashita, Chikamasa ; Ohdo, Shigehiro. / Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells. In: Cancer Research. 2013 ; Vol. 73, No. 8. pp. 2639-2649.
@article{31fe43663ad84f9287fc3c57065642a5,
title = "Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells",
abstract = "The sensitivity of cancer cells to chemotherapeutic agents varies according to circadian time. Most chemotherapeutic agents ultimately cause cell death through cell-intrinsic pathways as an indirect consequence of DNA damage. The p53 tumor suppressor gene (TRP53) configures the cell deaths induced by chemotherapeutic agents. In this study, we show that the transcription factor ATF4, a component of the mammalian circadian clock, functions in circadian accumulation of p53 protein in tumor cells. In murine fibroblast tumor cells, ATF4 induced the circadian expression of p19ARF (Cdkn2a). Oscillation of p19ARF interacted in a time-dependent manner with MDM2, a specific ubiquitin ligase of p53, resulting in a rhythmic prevention of its degradation by MDM2. Consequently, the half-life of p53 protein varied in a circadian timedependent manner without variation in mRNA levels. The p53 protein accumulated during those times when the p19ARF-MDM2 interaction was facilitated. Notably, the ability of the p53 degradation inhibitor nutlin-3 to kill murine fibroblast tumor cells was enhanced when the drug was administered at those times of day during which p53 had accumulated. Taken together, these results suggested that ATF4-mediated regulation of the p19ARF-MDM2 pathway underlies the circadian accumulation of p53 protein in malignant cells. Furthermore, they suggest an explanation for how the sensitivity of cancer cells to chemotherapeutic agents is enhanced at those times of day when p53 protein has accumulated, as a result of circadian processes controlled by ATF4.",
author = "Michiko Horiguchi and Satoru Koyanagi and Hamdan, {Ahmed M.} and Keisuke Kakimoto and Naoya Matsunaga and Chikamasa Yamashita and Shigehiro Ohdo",
year = "2013",
month = "4",
day = "15",
doi = "10.1158/0008-5472.CAN-12-2492",
language = "English",
volume = "73",
pages = "2639--2649",
journal = "Cancer Research",
issn = "0008-5472",
number = "8",

}

TY - JOUR

T1 - Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells

AU - Horiguchi, Michiko

AU - Koyanagi, Satoru

AU - Hamdan, Ahmed M.

AU - Kakimoto, Keisuke

AU - Matsunaga, Naoya

AU - Yamashita, Chikamasa

AU - Ohdo, Shigehiro

PY - 2013/4/15

Y1 - 2013/4/15

N2 - The sensitivity of cancer cells to chemotherapeutic agents varies according to circadian time. Most chemotherapeutic agents ultimately cause cell death through cell-intrinsic pathways as an indirect consequence of DNA damage. The p53 tumor suppressor gene (TRP53) configures the cell deaths induced by chemotherapeutic agents. In this study, we show that the transcription factor ATF4, a component of the mammalian circadian clock, functions in circadian accumulation of p53 protein in tumor cells. In murine fibroblast tumor cells, ATF4 induced the circadian expression of p19ARF (Cdkn2a). Oscillation of p19ARF interacted in a time-dependent manner with MDM2, a specific ubiquitin ligase of p53, resulting in a rhythmic prevention of its degradation by MDM2. Consequently, the half-life of p53 protein varied in a circadian timedependent manner without variation in mRNA levels. The p53 protein accumulated during those times when the p19ARF-MDM2 interaction was facilitated. Notably, the ability of the p53 degradation inhibitor nutlin-3 to kill murine fibroblast tumor cells was enhanced when the drug was administered at those times of day during which p53 had accumulated. Taken together, these results suggested that ATF4-mediated regulation of the p19ARF-MDM2 pathway underlies the circadian accumulation of p53 protein in malignant cells. Furthermore, they suggest an explanation for how the sensitivity of cancer cells to chemotherapeutic agents is enhanced at those times of day when p53 protein has accumulated, as a result of circadian processes controlled by ATF4.

AB - The sensitivity of cancer cells to chemotherapeutic agents varies according to circadian time. Most chemotherapeutic agents ultimately cause cell death through cell-intrinsic pathways as an indirect consequence of DNA damage. The p53 tumor suppressor gene (TRP53) configures the cell deaths induced by chemotherapeutic agents. In this study, we show that the transcription factor ATF4, a component of the mammalian circadian clock, functions in circadian accumulation of p53 protein in tumor cells. In murine fibroblast tumor cells, ATF4 induced the circadian expression of p19ARF (Cdkn2a). Oscillation of p19ARF interacted in a time-dependent manner with MDM2, a specific ubiquitin ligase of p53, resulting in a rhythmic prevention of its degradation by MDM2. Consequently, the half-life of p53 protein varied in a circadian timedependent manner without variation in mRNA levels. The p53 protein accumulated during those times when the p19ARF-MDM2 interaction was facilitated. Notably, the ability of the p53 degradation inhibitor nutlin-3 to kill murine fibroblast tumor cells was enhanced when the drug was administered at those times of day during which p53 had accumulated. Taken together, these results suggested that ATF4-mediated regulation of the p19ARF-MDM2 pathway underlies the circadian accumulation of p53 protein in malignant cells. Furthermore, they suggest an explanation for how the sensitivity of cancer cells to chemotherapeutic agents is enhanced at those times of day when p53 protein has accumulated, as a result of circadian processes controlled by ATF4.

UR - http://www.scopus.com/inward/record.url?scp=84876951396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876951396&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-2492

DO - 10.1158/0008-5472.CAN-12-2492

M3 - Article

C2 - 23580573

AN - SCOPUS:84876951396

VL - 73

SP - 2639

EP - 2649

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -